Our client has an advanced academic background in chemical science and extensive research experience spanning organic synthesis, chemical biology, protein regulation, and drug discovery. His research has resulted in peer-reviewed publications in highly regarded scientific journals and has been independently cited and utilized by researchers working in related areas. Rather than defining his proposed endeavor broadly as conducting chemical biology or pharmaceutical research, we developed a specific and forward-looking research direction centered on developing molecular screening platforms and targeted protein degradation technologies to expand therapeutic approaches for cancer and neurodegenerative diseases.
A key component of our strategy was establishing a tangible research scope and goal. The proposed endeavor was not framed merely around the general importance of cancer research or drug development. Instead, we identified how the client intended to advance targeted protein degradation through specific research directions, including technologies designed to selectively eliminate disease-associated proteins and improve the precision and effectiveness of therapeutic development. This allowed us to connect his technical expertise and future research plans to broader challenges involving cancer, Alzheimer’s disease, and other serious diseases while maintaining a defined scientific trajectory.
The client’s publication and citation profile also required careful positioning. At the time of filing, he had authored three peer-reviewed journal articles and two preprints, with approximately 25 citations. Several of his publications were relatively recent, meaning that relying solely on cumulative citation numbers would not have accurately reflected the trajectory or potential impact of his research. We therefore focused not simply on how many times his work had been cited, but on where his research had been published, how quickly newer publications were attracting attention, how his citation performance compared with other publications from similar fields and publication years, and how independent researchers were using his findings in subsequent work.
This became increasingly significant as the case progressed. By the RFE stage, the client’s citation record had grown from approximately 25 to 38 citations, providing additional evidence that his research influence was continuing to develop. Rather than presenting this increase as a raw numerical achievement, we contextualized the growth through field- and year-specific citation benchmarks. This analysis showed that multiple publications were performing strongly relative to comparable research, including a recently published article that had already reached the top 10% most cited publications in its field and publication year.
The recency of the client’s publications was therefore an important part of the strategy rather than simply a limitation. Citation accumulation takes time, particularly for newly published scientific work. By examining citation performance relative to publication year and documenting continued citation growth, we were able to present a more accurate picture of the client’s research trajectory. We further strengthened this evidence by identifying examples in which independent researchers had relied upon or implemented his findings, demonstrating that his work was already contributing to subsequent scientific investigations rather than simply appearing in academic literature.
To establish the broader significance of that trajectory, we connected the client’s specific research goals to recognized U.S. priorities in biomedical innovation, precision medicine, cancer research, and neurodegenerative disease. His proposed work seeks to expand the range of disease-related proteins that can potentially be targeted therapeutically and to develop more precise approaches for controlling protein activity. The petition therefore focused on the prospective impact of the specific technologies he intended to advance, rather than relying merely on the general importance of the biomedical field. The supporting evidence further demonstrated the significant health and economic burden of cancer and neurodegenerative diseases in the United States and the continuing national interest in developing innovative therapeutic approaches to address them.
We also presented a cohesive body of evidence demonstrating why the client was well positioned to carry this work forward. His academic training, publication record, citation trajectory, independent use of his research, ongoing projects, planned research, and expert recognition were not treated as isolated credentials. Instead, each piece of evidence was connected to the same forward-looking research objective. This was particularly important because the NIW analysis is not simply about demonstrating that a researcher has impressive credentials; it requires showing how the individual’s existing record provides a credible foundation for advancing the proposed endeavor.
By connecting these elements into one coherent research trajectory, we were able to demonstrate not only what our client had already accomplished, but also what he intends to accomplish next, why his background positions him to do so, and why the continued advancement of that work carries broader significance for the United States.
